Home/TECLens/Patrick Lopath
PL

Patrick Lopath

COO

TECLens

Therapeutic Areas

TECLens Pipeline

DrugIndicationPhase
qCXL™ for PresbyopiaPresbyopia (age-related near vision loss)Pre-clinical
qCXL™ for KeratoconusKeratoconus (corneal thinning disorder)Pilot Clinical Study Completed
qCXL™ for HyperopiaHyperopia (farsightedness)Research/Exploration
qCXL™ for MyopiaProgressive Myopia in Children & Low-order Myopia in AdultsResearch/Exploration